Literature DB >> 2155375

Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis.

M Musiani1, M L Zerbini, A Muscari, G M Puddu, G Gentilomi, D Gibellini, G Gallinella, P Puddu, M La Placa.   

Abstract

The immune response against Cytomegalovirus (CMV) and Epstein-Barr virus (EBV)-induced antigens has been determined in teh sera of 36 patients with angiographically assessed atherosclerosis and compared with that of 36 matched control subjects. Significantly higher titres of antibody against CMV and EBV - induced antigens and a significant increase in CMV- and EBV- reactivated infections were found in atherosclerotic patients as compared to control subjects. Moreover serological signs of concomitant EBV and CMV infections occurred more frequently in atherosclerotic patients than in controls. One atherosclerotic patient, however, completely lacked antibody to CMV while CMV- and EBV- reactivated infections were also noted in control subjects, probably connected with their old age. Our data suggest that multiple reactivations of latent viruses may represent a consequence rather than a causal factor of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155375

Source DB:  PubMed          Journal:  Microbiologica        ISSN: 0391-5352


  3 in total

Review 1.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  Persistent infection, inflammation, and functional impairment in older Latinos.

Authors:  Allison E Aiello; Mary N Haan; Christine M Pierce; Amanda M Simanek; Jersey Liang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-06       Impact factor: 6.053

3.  Detection of human cytomegalovirus and epstein-barr virus in coronary atherosclerotic tissue.

Authors:  Ana Vitória Imbronito; Silvia Linardi Marcelino; Sabrina Rosa Grande; Fabio Daumas Nunes; Giuseppe Alexandre Romito
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.